2nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK
Scientific Tracks Abstracts
-
A Report of Cytogenetic abnormalities Found In 246 Mexican patients clinically diagnosed with Myelodysplastic Syndrome (MDS), given the importance of Cytogenetic results in calculating the Risk Assessment proposed by the IPSS-R
Hematol Blood Disord
Marcelo F Rosales -
Cell-mediated immunotherapy of cancer by intentionally mismatched donor lymphocytes
Hematol Blood Disord
Shimon Slavin -
Diagnostic difficulties in myelodysplasia: Role of morphology and molecular techniques in age related clonality, cytopenia and life-style choices
Hematol Blood Disord
Manzoor Mangi -
Molecular and laboratory characteristics of recessive von Willebrand Disease 2N anno 2018
Hematol Blood Disord
Jan Michiels -
Novel insights in the diagnosis and classification of autosomal recessive and dominant von Willebrand diseases anno 2018
Hematol Blood Disord
Jan Michiels -
SLE as a hematological problem & the Kozhikode criterion for diagnosis of SLE
Hematol Blood Disord
Sasidharan P K -
When do we stop? Modern sequential therapies for hematologic malignancies and end of life questions
Hematol Blood Disord
H Joachim Deeg